Physician profile
Getinet D Ayalew
NPI 1326235797
$741.33
in general payments reported to CMS, 2019-2025
23 companies · $37.28 in 2025
The $37.28 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.70 · 2022: $43.29 · 2023: $614 · 2025: $37.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kite Pharma, INC. | $75.90 | 2023 | Yescarta |
| Celgene Corporation | $69.00 | 2023 | Pomalyst, Reblozyl, Opdualag |
| Novartis Pharmaceuticals Corporation | $58.70 | 2023 | |
| Pharmacyclics LLC, An Abbvie Company | $56.13 | 2023 | Epkinly |
| Regeneron Healthcare Solutions, INC. | $55.65 | 2023 | Libtayo |
| Beigene USA, INC. | $54.38 | 2023-2025 | Brukinsa |
| Astellas Pharma US INC | $46.62 | 2021-2023 | Padcev |
| Seagen INC. | $40.78 | 2023 | Tukysa |
| Merck Sharp & Dohme LLC | $37.66 | 2023 | Keytruda, Lynparza |
| Mirati Therapeutics, INC. | $28.64 | 2023 | Krazati |
| Stemline Therapeutics INC. | $24.91 | 2023 | Orserdu |
| Janssen Biotech, INC. | $24.07 | 2023 | |
| Genzyme Corporation | $21.49 | 2023 | |
| Lilly USA, LLC | $19.00 | 2023 | Jaypirca |
| Pfizer INC. | $17.60 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aveo Pharmaceuticals, INC. | $15.91 | 2023 | Fotivda |
| Daiichi Sankyo INC. | $15.19 | 2022 | |
| Array Biopharma INC | $14.27 | 2023 | Braftovi, Xalkori, Mektovi |
| Sobi, INC | $14.20 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.90 | 2022 | |
| Emd Serono, INC. | $13.71 | 2025 | |
| Gilead Sciences, INC. | $11.92 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Getinet Ayalew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.